In terms of fundamentals, Pfizer currently boasts a market capitalization of $132 billion. Over the last twelve months, the ...

Once a market darling during the early pandemic years, Pfizer (NYSE: PFE) has been on a straight southbound path for several ...

The earnings season enters its second busiest week. After the shockingly weak jobs report, concerns about the economy creep ...

Wall Street has no breathing room this week as August kicks off with a flood of economic data, high-stakes Fed talk, and ...

As Wall Street embarks on the first full week of August, the earnings wave continues with another stacked week of reports ...

Markets enter a critical week following Friday's dramatic selloff that delivered the worst one-day loss in months for major ...

US pharmaceutical giant Pfizer and German firm BioNTech lost Friday a court appeal in the latest step of a multi-million ...

With BLS data suddenly suspect, can the markets trust nonfarm payrolls and the CPI? Palantir and McDonald’s among those ...

Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.

The White House announced on Thursday that President Trump sent 17 major pharmaceutical companies letters delineating the ...

Concerns over US economic growth have taken center stage despite a solid corporate earnings season from S&P 500 companies.

AbbVie ( ABBV) on Thursday recorded better-than-expected financials for Q2 2025 and raised its full-year earnings outlook as the company’s newer immunology drugs offset a sharp sales decline for its ...